Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
536.60 |
572.80 |
595.36 |
578.45 |
621.32 |
Operating profit |
141.45 |
172.56 |
167.08 |
193.16 |
206.43 |
Interest |
0.36 |
0.39 |
0.40 |
0.40 |
0.12 |
Gross profit |
144.21 |
173.86 |
172.05 |
194.62 |
209.15 |
EPS (Rs) |
7.99 |
9.69 |
9.69 |
11.05 |
11.95 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
3.13 |
1.69 |
5.37 |
1.85 |
2.84 |
Stock adjustment |
-9.14 |
-0.93 |
3.68 |
-50.17 |
-19.37 |
Raw material |
247.84 |
243.13 |
269.40 |
298.21 |
299.74 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
72.26 |
71.05 |
66.71 |
48.13 |
43.81 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
84.20 |
87.00 |
88.49 |
89.12 |
90.70 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
14.53 |
13.18 |
13.13 |
12.61 |
11.52 |
Taxation |
31.74 |
41.92 |
40.19 |
46.55 |
51.27 |
Net profit / loss |
97.94 |
118.77 |
118.74 |
135.45 |
146.36 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
24.51 |
24.51 |
24.51 |
24.51 |
24.51 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
26.36 |
30.12 |
28.06 |
33.39 |
33.22 |
GPM (%) |
26.72 |
30.26 |
28.64 |
33.54 |
33.51 |
NPM (%) |
18.15 |
20.67 |
19.77 |
23.34 |
23.45 |